Language
Inter-Pharma – pharmaceutical solutions in Europe

News topic

Active ingredient Bleomycin Sulfate

Current shortage notices for the active ingredient Bleomycin Sulfate, structured by product, country and reporting period.

3 notices

← All shortages

What the Bleomycin Sulfate notices indicate for the supply chain

The 3 consolidated notices from Belgium are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Belgium

Bleomycine Hikma 15 000 IU inj. sol. (pwdr.) i.m./i.perit./i.tumor./i.v./i.pleur./i.arter./s.c. vial 15000 IU

Active ingredient: Bleomycin Sulfate

View notice details →
Belgium

Bleomycine Hikma 15 000 IU inj. sol. (pwdr.) i.m./i.perit./i.tumor./i.v./i.pleur./i.arter./s.c. vial 15000 IU

Active ingredient: Bleomycin Sulfate

View notice details →
Belgium

Bleomycine Hikma 15 000 IE inj. opl. (pdr.) i.m./i.perit./i.tumor./i.v./i.pleur./i.arter./s.c. flac. 15000 IE

Active ingredient: Bleomycin Sulfate

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.